When you enter multiple keywords separated by space, your search will contain results that match any of the keywords (OR search).
  • 31 Hits
  • Search Condition : Filter (MeSH = Antineoplastic Combined Chemotherapy Protocols / therapeutic use*)
Species Resource Title
Human and Animal Cells LC-2/ad(RCB0440) HADHA is a potential predictor of response to platinum-based chemotherapy for lung cancer.
Human and Animal Cells , General Microbes TE-8(RCB2098) , TE-10(RCB2099) , JCM8532 Fusobacterium nucleatum confers chemoresistance by modulating autophagy in oesophageal squamous cell carcinoma.
Human and Animal Cells HSC-2(RCB1945) , Ca9-22(RCB1976) , SAS(RCB1974) Synergetic Effects of PARP Inhibitor AZD2281 and Cisplatin in Oral Squamous Cell Carcinoma in Vitro and in Vivo.
Human and Animal Cells Y79(RCB1645) , WERI-Rb-1(RCB2146) Synergistic Effect of Curcumin in Combination with Anticancer Agents in Human Retinoblastoma Cancer Cell Lines.
Human and Animal Cells PK-8(RCB2700) , KLM-1(RCB2138) Cancer-Specific Targeting of Taurine-Upregulated Gene 1 Enhances the Effects of Chemotherapy in Pancreatic Cancer.
Human and Animal Cells HHUA(RCB0658) PK11195 enhances chemosensitivity to cisplatin and paclitaxel in human endometrial and ovarian cancer cells.
Human and Animal Cells ACC-MESO-1(RCB2292) , ACC-MESO-4(RCB2293) Combined use of irinotecan and p53 activator enhances growth inhibition of mesothelioma cells.
Human and Animal Cells HCT116(RCB2979) KRT17 as a prognostic biomarker for stage II colorectal cancer.
DNA material Genome Network Project Human cDNA Clone IRAL004L19 (HGY081883) JMJD2A sensitizes gastric cancer to chemotherapy by cooperating with CCDC8.
Human and Animal Cells StromaNKtert(RCB2350) Bruton's tyrosine kinase inhibition increases BCL-2 dependence and enhances sensitivity to venetoclax in chronic lymphocytic leukemia.
Human and Animal Cells HuH-7 Phospho-ERK is a biomarker of response to a synthetic lethal drug combination of sorafenib and MEK inhibition in liver cancer.
Human and Animal Cells SLVL(RCB1702) Combination lenalidomide-rituximab immunotherapy activates anti-tumour immunity and induces tumour cell death by complementary mechanisms of action in follicular lymphoma.
Human and Animal Cells TFK-1(RCB2537) Combined Gemcitabine and Metronidazole Is a Promising Therapeutic Strategy for Cancer Stem-like Cholangiocarcinoma.
Human and Animal Cells TE-11(RCB2100) High Expression of the Mitophagy-Related Protein Pink1 is Associated with a Poor Response to Chemotherapy and a Poor Prognosis for Patients Treated with Neoadjuvant Chemotherapy for Esophageal Squamous Cell Carcinoma.
Human and Animal Cells LM8(RCB1450) The effect of immune checkpoint inhibitors on lung metastases of osteosarcoma.
Human and Animal Cells StromaNKtert(RCB2350) Evaluation of bendamustine in combination with fludarabine in primary chronic lymphocytic leukemia cells.
Human and Animal Cells PC-9(RCB4455) Clinical outcome according to the level of preexisting epidermal growth factor receptor T790M mutation in patients with lung cancer harboring sensitive epidermal growth factor receptor mutations.
Human and Animal Cells Combination therapy of cilengitide with belotecan against experimental glioblastoma.
Human and Animal Cells Novel HSP90 inhibitor NVP-AUY922 enhances the anti-tumor effect of temsirolimus against oral squamous cell carcinoma.
Human and Animal Cells ACC-MESO-4(RCB2293) SOCS-1 gene delivery cooperates with cisplatin plus pemetrexed to exhibit preclinical antitumor activity against malignant pleural mesothelioma.